Veeva Systems Inc Class AVeeva's cloud-based life sciences solutions directly benefit from the pharmacovigilance automation market growth.
The global pharmacovigilance automation market is projected to grow from USD 2.80 billion in 2025 to USD 5.25 billion by 2035, at a compound annual growth rate of 6.50 percent. Software held a 72.40 percent share of the market in 2025, while the services segment is the fastest growing at a CAGR of 8.77 percent. Cloud-based deployment accounted for 49.80 percent of the market in 2025, and the SaaS segment is expected to record the highest CAGR of 13.02 percent. Artificial intelligence dominated with a 41.30 percent share in 2025, and natural language processing is the fastest growing technology segment at a CAGR of 13.73 percent. Pharmaceutical companies led end users with a 58.60 percent share in 2025, while biotechnology companies are the fastest growing at a CAGR of 11.57 percent. North America held a 38.60 percent share of the global market in 2025, and the Asia-Pacific region is the fastest growing regional market with a CAGR of about 8.92 percent.
Veeva Systems Inc Class AVeeva's cloud-based life sciences solutions directly benefit from the pharmacovigilance automation market growth.
IQVIA Holdings IncMarket growth forecast for pharmacovigilance automation benefits IQVIA as a leading provider of such services.
Oracle CorporationOracle's cloud and SaaS offerings align with the growing cloud-based and SaaS segments in pharmacovigilance automation.